Progressive Care Inc (fka RXMD)

[Jimmy Quick]

There are factors and details that are being ignored in the calculation. 340B scripts, these revenues are not reported, only the fees and this portion of the business has increased by over 150% since last year.

Example: Let's say net revenue for drug is $50 and the cost is $35. Well instead of recording net revenue of $50, RXMD is recording $35 for the fee amount received. Oh that is a 30% reduction in revenue per script.

These 340B scripts and fees play a huge factor and the changes in compounding reimbursement obviously has affected this as well.

And how would I know this?

Because the company has transparently told us so either in Financial Statements or PRs.

Dang it I just shot that theory all to heck.

Better luck next time.